does tirzepatide cause allodynia GLP-1 Drugs: New Reports of Dysesthesia and Understanding Allodynia: A Side Effect

In this Phase 3b, open-label, randomized controlled clinical trial, 751 adult participants with obesity but without type 2 diabetes (BMI 30 or BMI 27 with at least one obesity-related comorbidity, such as hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease) were randomly assigned in a 1:1 ratio to receive once-weekly subcutaneous injections of the maximum tolerated dose of Tirzepatide (10 mg or 15 mg) or Semaglutide (1.7 mg or 2.4 mg) for 72 weeks

Many prescribers say yes

AlphaScreen reagents, 125 I-Ex(939), 125 I-hGLP-1 and 384-well ProxiPlates were purchased from PerkinElmer Life and Analytical Sciences (Waltham, MA)

Even without these further pharmacological developments, there are steps patients and their providers can take right now to maintain muscle as weight is lostboth quantity and quality